If you've ever had a urinary tract infection (UTI), you know how miserable it can be: the burning, the itching, the constant trips to the bathroom. Now imagine going through round after round of ...

Ahead of an Antimicrobial Drugs Advisory Committee meeting on Monday, FDA reviewers voiced ongoing concerns about the benefits versus risks of a novel oral antibiotic for the treatment of ...

Cefdinir showed nearly double the treatment failure rate compared to cephalexin in outpatient uUTI management. Cefdinir's lower bioavailability and urinary excretion contribute to its reduced efficacy ...

First-line treatment of uncomplicated urinary tract infection (UTI) in adolescent and adult English women often fails to follow national guidelines, potentially necessitating more prescriptions and ...

The first ever clinical trial dedicated to improving the treatment of chronic urinary tract infections (UTI) could pave the way for more NHS clinics to offer extended courses of antibiotics. It comes ...

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials, ...

While more common in females, urinary tract infections can also affect males. Symptoms include a sudden urge to urinate, frequent urination, and a burning sensation when you urinate. UTIs occur when ...

New research found that an experimental, faster test matched standard lab methods about 96.95% of the time when identifying effective antibiotics for UTI treatment. Lab cultures can take anywhere from ...

Firsts are freaky, but they don’t have to be. In Her Campus’s series My First Time, we’re answering the burning questions you might be uncomfortable asking about IRL. In this article, we tackle what ...